Substance P/Neurokinin-1 Receptor Antagonist drugs compared

Compare all 5 Substance P/Neurokinin-1 Receptor Antagonist drugs side by side. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores.

Full ranking · 5 drugs

Frequently asked questions

What is the Substance P/Neurokinin-1 Receptor Antagonist drug class?

Substance P/Neurokinin-1 Receptor Antagonist is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 5 Substance P/Neurokinin-1 Receptor Antagonist products, each independently rated.

Are all Substance P/Neurokinin-1 Receptor Antagonist drugs the same?

No. Substance P/Neurokinin-1 Receptor Antagonist drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.

Sources: the Substance P/Neurokinin-1 Receptor Antagonist class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class). Ratings are pharmaranks’ independent FDA recall-safety analysis.